Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road
Trade

World Insights: EU open to use of approved COVID-19 vaccines

February 04, 2021


Abstract : European leaders have shown an openness to the use of COVID-19 vaccines developed by any supplier once they pass the European Union's (EU) tests.

BRUSSELS, Feb. 4 (Xinhua) -- European leaders have shown an openness to the use of COVID-19 vaccines developed by any supplier once they pass the European Union's (EU) tests.

European Commission President Ursula von der Leyen said Tuesday that coronavirus vaccines from Russia and China could be approved for use in the EU if they "show all the data," AFP quoted the bloc's lawmakers as saying.

If Chinese producers "show all the data... then they could get... a conditional market authorization like the other ones," von der Leyen told EU lawmakers at a meeting.

A commission spokesman said Tuesday that one of the criteria for the EU contracts for vaccines was that producers had the capacity to produce them inside the bloc.

Europe is now facing a vaccine shortage as pharmacies are supplying vaccines slower than anticipated.

The EU has so far signed agreements with six vaccine suppliers but the vaccines approved by the bloc are from U.S.-Germany joint venture Pfizer and BioNTech, British-Swedish multinational AstraZeneca, and Moderna from the United States.

German Chancellor Angela Merkel said Tuesday that every COVID-19 vaccine is welcome in the EU as the bloc is facing vaccine delivery difficulties.

"Serbia is vaccinating faster. Serbia is vaccinating with the Chinese vaccine. We have always said that every vaccine trying to obtain approval from the European Medicines Agency (EMA) is very welcome," Merkel said in a televised interview with the German public broadcast ARD program "Farbe bekennen."

The German chancellor affirmed that by the end of summer everyone in Germany could be able to get at least the first of the two necessary vaccinations. So far nothing has gone wrong with the national vaccination campaign.

Merkel's remarks were echoed by French President Emmanuel Macron, who said that all vaccines that are approved by European and national health authorities will be welcome in France.

Decision-making on vaccine should be scientific, rather than political, Macron told TF1 television on Tuesday.

Spanish Health Minister Carolina Darias said Wednesday that Spain will be "open" to the use of the Russian Sputnik V coronavirus vaccine once authorized by the EMA.

For now, Hungary is the only EU member state that has authorized the use of China's Sinopharm COVID-19 vaccine and the Russian vaccine.

One of EU's Balkan partners, Serbia, has approved a wide portfolio that includes vaccines produced in Russia and China. The country received a million doses of China's Sinopharm vaccines in mid-January. Enditem

Scan the QR code and push it to your mobile phone

Keyword: EU COVID-19 vaccines

Reading:

Oil consumption falls by 12.5 percent in 2020

Pakistani healthcare workers receive Chinese COVID-19 vaccines

Chinese FM meets Lao counterpart via video link

China Mobile opens second European data center in Frankfurt

Chinese conventional carmakers join hands with tech giants to inaugurate new development pattern

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial